Bovine Adrenal Medulla Dodecapeptide: Properties & Research Uses
Bovine Adrenal Medulla Dodecapeptide: Properties & Research Uses
Bovine adrenal medulla dodecapeptide is a naturally occurring twelve-amino-acid opioid neuropeptide derived from the proteolytic processing of proenkephalin A in bovine adrenal medullary chromaffin cells, serving as a key intermediate in the biosynthetic pathway that ultimately yields Met-enkephalin.
- Common Abbreviation
- BAM-12P (Bovine Adrenal Medulla 12P)
- Peptide Length
- 12 amino acids
- Biological Source
- Bovine adrenal medullary chromaffin cells
- Precursor Protein
- Proenkephalin A (PENK)
- N-terminal Sequence
- Contains Met-enkephalin (Tyr-Gly-Gly-Phe-Met) at the N-terminus
- Receptor Activity
- Opioid receptor agonist (primarily mu and delta opioid receptors)
- Research Application
- Pain modulation, neuroendocrine signaling, opioid biology
What Is Bovine Adrenal Medulla Dodecapeptide?
Bovine adrenal medulla dodecapeptide, widely referred to as BAM-12P, is a twelve-amino-acid peptide originally isolated from bovine adrenal medullary tissue. It is generated through the sequential proteolytic processing of proenkephalin A (PENK), a large precursor polyprotein that encodes multiple copies of Met-enkephalin and Leu-enkephalin flanked by paired basic residues recognized by prohormone convertases.
BAM-12P retains the complete Met-enkephalin pentapeptide (Tyr-Gly-Gly-Phe-Met) at its N-terminus, followed by seven additional C-terminal residues. This structural feature allows it to interact with opioid receptors while also possessing distinct pharmacological properties relative to the shorter enkephalin fragments. Because it is a direct biosynthetic intermediate, BAM-12P occupies a central position in studies of opioid peptide maturation and chromaffin cell secretion.
The peptide is stored in large dense-core vesicles within adrenal medullary chromaffin cells alongside catecholamines, and is co-released upon sympathetic stimulation, underscoring its physiological relevance in stress and autonomic responses.
Biochemical Structure and Stability
BAM-12P is a linear peptide with the amino acid sequence Tyr-Gly-Gly-Phe-Met-Arg-Gly-Leu-Ser-Trp-Leu-Gln, though researchers should consult the product datasheet for the confirmed sequence of the specific lot supplied by Aladdin Scientific. The presence of methionine in position 5 renders the peptide susceptible to oxidation; consequently, stock solutions should be prepared under inert atmosphere conditions where possible and stored at −20 °C or below in aliquots to minimize freeze-thaw degradation.
The peptide is typically supplied as a lyophilized white powder with a defined purity (commonly ≥95% by HPLC) and confirmed by mass spectrometry. Reconstitution is generally performed in sterile water or dilute acetic acid (0.1% v/v), followed by further dilution in the appropriate physiological buffer. Avoid repeated freeze-thaw cycles, as these can promote aggregation and methionine oxidation, both of which reduce biological potency.
Molecular weight and exact purity specifications vary by lot; always refer to the Certificate of Analysis (CoA) provided with each batch from Aladdin Scientific to confirm these parameters before use in quantitative assays.
Biological Activity and Mechanisms of Action
BAM-12P exerts its primary biological effects through activation of opioid receptors, particularly the mu (MOR) and delta (DOR) opioid receptor subtypes. By binding to these G protein-coupled receptors (GPCRs), the peptide triggers inhibition of adenylyl cyclase, reduction of intracellular cAMP levels, modulation of voltage-gated calcium channels, and activation of inwardly rectifying potassium channels — a convergent set of signaling events that collectively suppress neuronal excitability and neurotransmitter release.
Compared with free Met-enkephalin, BAM-12P generally exhibits greater resistance to enzymatic degradation by enkephalinases (neutral endopeptidase, aminopeptidase N) due to the additional C-terminal extension, which can sterically hinder access of these peptidases to cleavage sites. This confers a relatively prolonged duration of receptor engagement in in vitro assays, making BAM-12P a useful tool for studying opioid receptor kinetics and desensitization.
Beyond classic opioid receptor pathways, BAM-12P has been investigated for potential interactions with the Mas-related G protein-coupled receptor X2 (MRGPRX2) on mast cells and sensory neurons, placing it in the growing field of itch and nociception research. These non-opioid interactions are an active area of investigation and researchers should treat published data in this area with appropriate scrutiny pending broader replication.
Research Applications
Opioid Receptor Pharmacology: BAM-12P is used as a reference agonist in radioligand binding displacement assays and functional cAMP inhibition assays to characterize opioid receptor affinity, selectivity, and signaling efficacy. Its intermediate length between enkephalins and larger proenkephalin-derived peptides makes it valuable for structure-activity relationship (SAR) studies aimed at identifying the minimal sequence requirements for receptor subtype selectivity.
Neuropeptide Processing Studies: Because BAM-12P is a defined processing intermediate of proenkephalin A, it is employed as a substrate or product standard in in vitro prohormone convertase (PC1/3, PC2) and carboxypeptidase E (CPE) activity assays. These experiments help elucidate the ordered proteolytic cascade that governs opioid peptide maturation in secretory cells.
Pain and Nociception Models: In rodent models, synthetic BAM-12P is administered intrathecally or intracerebroventricularly to assess antinociceptive potency and to probe the contribution of individual proenkephalin-derived fragments to spinal pain modulation. Such data inform the rational design of novel analgesic peptides.
Neuroendocrine and Stress Biology: Researchers studying the adrenal stress response use BAM-12P as a biomarker of chromaffin cell secretion, measuring its release alongside catecholamines in response to nicotinic stimulation or physiological stressors in ex vivo adrenal perfusion preparations.
Handling, Storage, and Quality Considerations
Reconstitution: Lyophilized BAM-12P should be reconstituted in sterile, nuclease-free water or 0.1% acetic acid to prepare a concentrated stock solution (typically 1 mg/mL). Allow the vial to equilibrate to room temperature before opening to prevent moisture condensation on the peptide powder. Briefly centrifuge the vial before opening to consolidate the lyophilizate at the bottom.
Storage Conditions: Store the lyophilized peptide at −20 °C, protected from light and moisture. Once reconstituted, prepare single-use aliquots and store at −80 °C. Avoid repeated freeze-thaw cycles. Under recommended storage conditions, the peptide is generally stable for up to 12 months from the date of receipt, but researchers should verify shelf-life with the CoA.
Handling Precautions: Although BAM-12P is not classified as a controlled substance in most jurisdictions, it is a biologically active opioid receptor agonist. Standard laboratory safe-handling practices apply: wear appropriate PPE (gloves, lab coat, eye protection), work in a well-ventilated area, and avoid inhalation of lyophilized powder during reconstitution. Refer to the Safety Data Sheet (SDS) provided by Aladdin Scientific before use.
Quality Assurance: Aladdin Scientific's BAM-12P (SKU: B118770) is characterized by HPLC for purity and by mass spectrometry for molecular identity. The CoA accompanies each lot and includes purity, molecular weight confirmation, and appearance data. Researchers requiring additional characterization data (e.g., amino acid analysis, endotoxin testing) should contact Aladdin Scientific technical support.
Frequently asked questions
What is the sequence of bovine adrenal medulla dodecapeptide (BAM-12P)?
BAM-12P is generally reported to have the sequence Tyr-Gly-Gly-Phe-Met-Arg-Gly-Leu-Ser-Trp-Leu-Gln, with Met-enkephalin (Tyr-Gly-Gly-Phe-Met) embedded at the N-terminus. Always confirm the exact sequence from the Certificate of Analysis supplied with your specific lot from Aladdin Scientific, as minor sequence variants have appeared in the literature.
How should I reconstitute and store BAM-12P to maintain its activity?
Reconstitute lyophilized BAM-12P in sterile water or 0.1% acetic acid to make a stock solution, then aliquot and store at −80 °C to avoid repeated freeze-thaw cycles. The methionine residue at position 5 is susceptible to oxidation, so minimize exposure to oxygen during handling and use antioxidants such as DTT cautiously if your downstream assay tolerates them.
Which opioid receptor subtypes does BAM-12P activate?
BAM-12P acts primarily as an agonist at mu (MOR) and delta (DOR) opioid receptors, consistent with its structural relationship to Met-enkephalin. Its relative affinity and selectivity profile differs from free Met-enkephalin due to the C-terminal extension, and precise Ki values may vary across published studies; refer to primary literature for quantitative binding data relevant to your experimental system.
Is BAM-12P a controlled substance?
BAM-12P is not listed as a scheduled controlled substance under most major regulatory frameworks (e.g., US DEA schedules), as it is a naturally occurring intermediate peptide used for research purposes. However, researchers should verify current regulations in their specific country or institution, as policies governing opioid-active research reagents can vary and may be subject to institutional biosafety or ethics committee oversight.
What are typical concentrations used for in vitro opioid receptor binding assays with BAM-12P?
Concentrations used in competitive radioligand binding assays typically range from subnanomolar to micromolar (e.g., 0.1 nM to 10 µM) to construct full displacement curves. The precise range depends on the receptor subtype, cell or membrane preparation used, and the radioligand employed. Pilot dose-response experiments are recommended to define the optimal concentration range for each specific assay format.
References
- Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975;258(5536):577-580. doi:10.1038/258577a0
- Stern AS, Lewis RV, Kimura S, Rossier J, Stein S, Udenfriend S. Opioid hexapeptides and heptapeptides in adrenal medulla and brain: possible implications on the biosynthesis of enkephalins. Proc Natl Acad Sci USA. 1980;77(9):5301-5305. PMID:6254070
- Noda M, Teranishi Y, Takahashi H, et al. Isolation and structural organization of the human preproenkephalin gene. Nature. 1982;297(5865):431-434. doi:10.1038/297431a0
- Fricker LD, Snyder SH. Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc Natl Acad Sci USA. 1982;79(12):3886-3890. doi:10.1073/pnas.79.12.3886
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)